Theravance Biopharma to Present at the 18th Annual Needham Healthcare Conference
A live broadcast will be available by visiting the Investor Relations section of
In pursuit of our purpose, we apply insights and innovation at each stage of our business and utilize our internal capabilities and those of partners around the world. We apply organ-selective expertise to biologically compelling targets to discover and develop medicines designed to treat underserved localized diseases and to limit systemic exposure, in order to maximize patient benefit and minimize risk. These efforts leverage years of experience in developing lung-selective medicines to treat respiratory disease, including
We have an economic interest in potential future payments from
For more information, please visit www.theravance.com.
THERAVANCE® and the Cross/Star logo are registered trademarks of the
View original content to download multimedia:http://www.prnewswire.com/news-releases/theravance-biopharma-to-present-at-the-18th-annual-needham-healthcare-conference-300822442.html